chrisvoncsefalvay/vaers-outcomes huggingface dataset:
muscle pain; joint pain; I could barely walk; Temperature increased slightly; sweating; soreness in the arm; Headache; Tiredness; chills; This is a spontaneous report from a contactable consumer. A 55-year-old female patient (non-pregnant) received first dose of BNT162B2 (lot number El9267), via an unspecified route of administration on left arm on 14Feb2021 at 13:00 at the age of 55 year old at a single dose for COVID-19 immunisation at hospital. Medical history included thyroid problems and hypertension. No Known allergies. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Concomitant medications included levothyroxine sodium (LEVOXYL) and lisinopril. The patient received other medications within 2 weeks of vaccination. On 07Feb2021 at 16:00, the patient experienced soreness in the arm, headache, tiredness, chills, on 08Feb2021, the next morning with severe soreness in the arm, very severe muscle and joint pain and could barely walk. On 08Feb2021, temperature increased slightly. Chills and sweating. It felt worse than the flu! This morning feeling better, still weak but better. Patient did take Alene to help with the muscle pain, soreness and could barely walk. Seriousness of all the events was reported as non-serious. No treatment was received in response to the adverse events temperature increased slightly, headache, tiredness, chills, joint pain and sweating. The patient was not diagnosed with COVID-19 prior to vaccination. Since the vaccination, patient was not tested for COVID-19. The patient was recovering from all the events.
Grandmother reports raised red wheal approximately the size of a half dollar. Warm to touch. Using Benadryl and cold compress. Grandmother is monitoring site and will seek evaluation by primary care provider if worsens
I have sensorineural hearing loss in my left ear.  Following the vaccine, the next day I had an increase in tinnitus and a decrease in speech recognition.  i also had fever, chills and fatigue.  My arm was very sore and bright red.  It was very hot to the touch.
Swelling, red streak down past elbow. Adverse event was gone 8/21/16 at night without medications.
stiff painful frozen shoulder symptoms  quickly developed with second covid shot in left arm, seen primary care doc/steroid shots,,,,got mri,  seen Orthopedic doc/thearpy    better but still sore and catching/popping
Patient has large red area approx 3 inch diameter with slight rash surrounding site.  Arm is warm to touch and sore.  Treatment with cool/ice pack. Instructed patient to seek medical attention if not better, worsened , or fever develops
Information has been received from a health professional concerning a patient who was vaccinated with a first, second, third, and fourth dose of Rotateq in April 2007, June 2007, August 2007 and 20-FEB-2008 (Lot# 657983/1243U), respectively. No adverse effect was reported. No product quality complaint was involved. Additional information has been requested.
No treatment. Significant headaches happening daily since last vaccine dose administered. Dizziness is accompanied with the severe headaches.
This  57  year old     male received the Covid shot on  4/21/21    and went to the ED on 4/27/21      and was admitted  on   4/27/21     with  the diagnoses listed below.  J18.9 - Multifocal pneumonia U07.1, J12.82 - Pneumonia due to COVID-19 virus J18.9 - Pneumonia, unspecified organism N17.9 - Acute kidney failure, unspecified
Pt was here of WCE / PE and 2nd GARDASIL shot (no incident w/first shot. After receiving shot pt passed out walking into waiting room, hit head hard (+) concussion.
(R) arm swollen around injection site. Redness at injection site. Warm to touch.
Peripheral Neuropathy in both feet; Muscle weakness; Toes curl up on both feet at night; Hands are locking up; Fell forward,  had to sit down; Pain in front both legs, debilitating; This serious case was reported by a consumer via call center representative and described the occurrence of peripheral neuropathy in a elderly male patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced peripheral neuropathy (Verbatim: Peripheral Neuropathy in both feet) (serious criteria GSK medically significant), muscle weakness (Verbatim: Muscle weakness), curly toe (Verbatim: Toes curl up on both feet at night), hand deformity (Verbatim: Hands are locking up), fall (Verbatim: Fell forward,  had to sit down) and leg pain (Verbatim: Pain in front both legs, debilitating). The patient was treated with medication unknown (Cream (Medication Unknown)). The outcome of the peripheral neuropathy, muscle weakness, curly toe, hand deformity and leg pain were not resolved and the outcome of the fall was not reported.   It was unknown if the reporter considered the peripheral neuropathy, muscle weakness, curly toe, hand deformity, fall and leg pain to be related to Shingrix.     It was unknown if the company considered the peripheral neuropathy, muscle weakness, curly toe, hand deformity, fall and leg pain to be related to Shingrix.   Additional Information: GSK Receipt Date: 11-APR-2023 The patient reported that approximately 2 years ago he had his second dose of Shingrix and was now experiencing muscle weakness/pain in both legs.  The first episode the patient experienced was within a relatively short time after having had the Shingrix vaccination.  The patient reported that he was out for an evening walk when he kind of fell forward and had to sat down.  For approximately 2 years, the weakness/pain had been sporadic in nature but when it occurs it is debilitating. The muscle weakness/pain presents in the front of both legs.  The patient reported that he had to got up in the middle of the night to put cream on legs to relieve the pain.  He stated that at some point during these past two years his toes on both feet have started curling up at night and that his hands are now locking up.  The patient had also been diagnosed with peripheral neuropathy in both feet during these past 2 years.  He was under the care of a neurologist that had done many tests to try and diagnosis his condition.  The patient stated that the neurologist is unable to diagnose his condition.  The patient called GlaxoSmithKline today after seeing a commercial on TV for Shingrix and reported that one of the side effects mentioned was muscle weakness. The patient called to know if there was a correlation with the onset of his condition over the past two years and the Shingrix vaccination. The reporter consented to follow up.
4:51pm  Patient c/o dizziness.  Patient fasting for religious reasons. Patient refused water.  Vitals:  B/P 138/87 P 93 RR16 O2 97%.
Soreness, itching, redness and heat at injection site began within minutes. On Monday July 22, 2019 3:00 pm noticed I had developed large tender lump in armpit area on the left side.
Pt presented to office 12/7 with 2 days of mild rash upper torso and arms and prominent, warm, red and tender right submandibular LAD  approx 2.5x3cm in size. Responded to Augmentin and followed by ENT. In retrospect, pt reports 1.5 wks after vaccination, he had a few isolated pruritic rashes as well. As of 12/19, patient noted last new lesion approximately 12/17/22.  Varicella PCR negative, though the lesions were dry at the time of sampling.  10/7/22 tx'd w Ceftin for maxillary sinusitis
This case was reported by a consumer and described the occurrence of not responding to therapy in a 52-year-old male subject who was vaccinated with ENGERIX B (GlaxoSmithKline). A physician or other health care professional has not verified this report. The subject's medical history included colonoscopy, rectal bleeding and umbilical hernia. Concurrent medical conditions included hepatitis c and sexually transmitted disease. Previous and/or concurrent vaccination included hepatitis A vaccine inactivated; manufacturer unspecified; unknown; unknown given on 2009. Concurrent medications included antibiotics. On unspecified dates in 2009, the subject received 1st, 2nd and 3rd dose of ENGERIX B (unknown). In 2009, at an unspecified time after vaccination with ENGERIX B, the subject experienced not responding to therapy. The subject reported he has had hepatitis C for 10 years and was recommended to have a hepatitis A and B vaccination series in 2009. The subject received both hepatitis A and B vaccination series in 2009. In the later part of 2009 it was discovered he didn't show antibodies for hepatitis B and he was revaccinated with hepatitis B in 2010 with three vaccinations. On unspecified date in 2010, the subject received 4th, 5th, and 6th dose of ENGERIX B (unknown). Two months ago in November 2010, the subject's blood tested negative for antibodies. On 15 November 2010, after an unspecified time after receiving the second ENGERIX B series the subject experienced ringing in the ears, arthritic conditions such as swelling, stiffness, tingling and numbness. The subject reported that he was treated for a sexually transmitted disease (STD) infection one month ago, with an antibiotic. The subject reported the ringing further described as "crickets" in the ear stopped after he received his antibiotic. The ringing stopped for one day but has returned periodically, occurring off and on now. The subject was recommended to repeat the series at double dose but he is refusing at this time. He also reported that he believed it was ENGERIX B that he received for both vaccination series. At the time of reporting the events of not responding to therapy, arthritis, swelling and stiffness were unresolved; events of cricket noises both ears, tingling and numbness were unspecified.
Patient presented to office on 10/24/19, 3 days after immunization.  Reported 2 days of fever with TMax 104, erythema and swelling of injection site at right arm, warm and tender to touch, continuing to spread.  At home tried Tylenol with improvement in fever reduction, Benadryl had no change.  He had also been taking Bactrim for finger cellulitis during that time and reported improvement.   Patient appeared acutely ill but stable, was afebrile in office T 100.1F, HR 105.  Injection site erythema measured 3x4inches, was warm, tender to palpation.    Reviewed case reports that showed 5 adult patients had similar reactions from receiving both influenza and PPSV 23.  Discussed with patient and guardian, did initial labwork as below.  Monitored and saw patient back the following day with decreasing fever curve and reduction in injection site swelling.  Did complain of abdominal pain and rectal bleeding at that time, but was found to have a superficial anal fissure on exam.
Slept over 10 hours next day. A few days after 2nd shot developed rash on both arms (maybe hives) that is still showing  on May 30th. Rash is still noticeable on both arms but less irritating. I had minor psoriasis on leg that seemed to get worse after 2nd shot.  Also within the last 10 day I fell and got 2 minor cuts on my arms. Usually, my cuts heals very quickly, but the 2 cuts I received did not heal fast. They were slow to heal and almost leaking puss. Overall, I feel my skin is slowly healing after any issue with cuts or rashes or minor psoriasis. In addition there were times up to the last week where I would feel very tired around midnight and just had to go to sleep. I normally don't go to sleep till after 12:30AM, but I was so I tired that I would be in bed by 12:00AM.
Janssen vaccine is only approved for patients 18 years of age or older it was given to the patient listed in this report who is only 15 years old.
No additional AE/PCQ reported; VAQTA administered after a temperature excursion; This spontaneous report was received from a medical assistance referring to a patient of unknown age and gender. The patient's medical history, concomitant medications, drug allergies, or reactions were not reported.   On 18-AUG-2021 the patient was vaccinated with a improperly stored dose of hepatitis a vaccine, inactivated(VAQTA) lot # T023913 has been verified to be valid expiration date 31-MAR-2021 for prophylaxis (strength and administration route were not provided) (product storage error).  The vaccine was exposed to a temperature above 9 Celsius degrees (C) for a time frame of 5 minutes; the vaccine did not experience previous temperature excursions, no adverse events were reported. combinationproductreport: Yes; brandname: VAQTA SYRINGE (DEVICE); commondevicename: Hepatitis A Vaccine, Inactivated; productcode: FMF; manufacturername: Merck; devicelotnumber: T023913; expirationdate: 31-MAR-2022; deviceage and unit: 0 ; operatorofdevice: Unknown; malfunction: Unknown; deviceusage: Initial; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not meet criteria for reportability
6 weeks since my 21 year old son got the first dose of vaccine; he is having exertional headaches; This spontaneous case was reported by a patient family member or friend and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (6 weeks since my 21 year old son got the first dose of vaccine) and EXERTIONAL HEADACHE (he is having exertional headaches) in a 21-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (6 weeks since my 21 year old son got the first dose of vaccine) and EXERTIONAL HEADACHE (he is having exertional headaches). At the time of the report, PRODUCT DOSE OMISSION ISSUE (6 weeks since my 21 year old son got the first dose of vaccine) and EXERTIONAL HEADACHE (he is having exertional headaches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported No treatment drugs were reported
Pt recvd vax & exp elevated BP, SOB, nausea, & was diaphoretic; hospitalized same day (16AUG93) & dx w/ allergic reaction;
Diverticulitis - underwent robotic cyst laparoscopic sigmoid colectomy.  Postoperatively he was started on a diet and advance as tolerated.  He had full return of bowel function and voiding without problem. Hospital admission within 6 weeks of receiving the COVID vaccine.
Minor psoriasis flare ups; This spontaneous case was reported by a patient and describes the occurrence of PSORIASIS (Minor psoriasis flare ups) in an adult male patient who received mRNA-1273 (Spikevax) for COVID-19 vaccination.    Co-suspect products included non-company products RISANKIZUMAB (SKYRIZI [RISANKIZUMAB]) for Plaque psoriasis and ADALIMUMAB (HUMIRA) for an unknown indication.    Concurrent medical conditions included Plaque psoriasis.   On an unknown date, the patient received dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form, RISANKIZUMAB (SKYRIZI [RISANKIZUMAB]) (Subcutaneous) at an unspecified dose and ADALIMUMAB (HUMIRA) (Subcutaneous) at an unspecified dose. On an unknown date, the patient experienced PSORIASIS (Minor psoriasis flare ups). At the time of the report, PSORIASIS (Minor psoriasis flare ups) had not resolved.        The action taken with mRNA-1273 (Spikevax) (Intramuscular) was unknown.       No concomitant product was reported. The patient was on Humira and he had an allergic reaction to the Humira, his whole body turned red. When he got his vaccinations, he did have minor psoriasis flare ups. He still had a few patches here and there. No treatment information was reported. It was unknown if patient was enrolled in a COVID-19 vaccine trial. This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.
Patient had rash spreading out from vaccinated arm in the hours/days following the rash.  Days after the vaccination, the patient did call 911 and epinephrine was administered as the patient was complaining of swelling in throat.
Only liquid portion was used; Only liquid portion was administered; This case was reported by a consumer via call center representative and described the occurrence of inappropriate preparation of medication in a 17-year-old male patient who received Men ACWY-CRM NVS (Menveo) for prophylaxis.   On 14th January 2023, the patient received Menveo. On 14th January 2023, unknown after receiving Menveo, the patient experienced inappropriate preparation of medication and inappropriate dose of vaccine administered. On an unknown date, the outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown.       Additional Information: GSK Receipt date: 18-Jan-2023. Reporter's Comments: The patient received Menveo on an unknown arm. The reporter stated that the liquid portion of the vaccine was injected. The reporter consented to follow up. Additional Supportive Information: The patient was injected only the liquid portion of Menveo which led inappropriate preparation of medication and inappropriate dose of vaccine administered .
Headache, Myalgia, Fever, heaviness on chest, fatigue narrative:
I started getting hives took Benadryl (immediately after before taking Prednisone for 3 months) and Hydroxyzine (wean myself off). I started Zolar two weeks ago feeling better.
Father reports client looked funny about 15 minutes after injection. Face looked blotchy only ate 1/2 of lunch. Father reports about 1pm client said he had a headaches, felt warm, felt like he was going to be sick. Mother called at approx 2:20 to say client had headache. Denied any additional symptoms. Family reports client had problem with his ear popping this summer. Completed ABX 1-2 weeks ago and has appt with ENT on 10/09/2006. Also reports client has severe migraines. Instructed to have client evaluated at school health center and told he had a cold in his kidney, because he was c/o back pain. Temp at health center was 99 deg. Family reports client feeling better today but still c/o back discomfort but client attending school.
Heard vaccinator say he was bleeding.  Felt lightheaded.  Laid on floor & came to quickly.  Did not lose consciousness per patient.   Patient reports feeling back to normal when he arrived in med obs #2 at 16:21.  Vitals at 16:22, HR 60, resp 16, BP 134/89, SaO2 9al4%.  Patient given a snack and water.  Patient's vitals at 16:29, HR 64, resp 16, BP 126/75, SaO2 95%.  Vitals at 16:43, HR 68, Resp 16, BP 131/81, SaO2 95%.  No lightheadedness at all in med obs#2.   Patient left at 16:45 via own vehicle.
VASCULITIS, PROGRESSIVE LEFT SHOULDER SWELLING CIRCUMFERENTIAL TO THE INOCULATION SITE WITH INCREASED VIOLACEOUS COLORATION. PT FEELS "A LITTLE OFF" C/O NOTABLE ITCH IN THE REACTION OF ERYTHEMA. C/O REDNESS, SWELLING, TENDERNESS. INCREASED VIOLACEOUS COLORATION, INCREASED ERYTHEMA MEDIALLY AND DISTALLY, PETECHIAE AND SMALL VESICLES NOTED.
pt complains of intermittent tingling and numbing of 2 fingers on her left hand (the same side the vaccine was administered on)
This case was reported by a pharmacist and described the occurrence of dizziness and nausea in a subject of unspecified age and gender who was vaccinated with ENGERIX B (GlaxoSmithKline). On an unspecified date the subject received unspecified dose of ENGERIX B (.5 ml). At an unknown time after vaccination with ENGERIX B, the subject experienced dizziness and nausea. At the time of reporting the outcome of the events were unspecified. This is one of three cases reported by this pharmacist where all three subjects experienced the same events with same lot number provided, see cases A0809417A and A0809419A for more details. No further information was provided.
My daughter had the first GARDASIL shot on 7/7/08.  7 to 10 days later she began having severe pains and cramping in her pelvic area along with redness, fever, vomiting, and joint pains.  Her doctor said it was just a reaction to the shot and after examining her told her to go home and take TYLENOL for headaches, pains, etc because she was the first case he had seen this severe and didn't know what to do other than to examine her once a month. Every week she has experienced severe joint pains, cramps, not feeling well enough to eat, etc.  She lost 10 lbs.  Since she is 17 years old and only weighed 105 lbs that didn't set well with me.  She is naturally skinny.  The gynecologist still doesn't know what to do with my daughter's pains.  He did an EKG, ultrasound, urine test and they all came back ok. The ultrasound showed an enlarged cyst on one of her ovaries.  This is getting ridiculous in the fact that she can no longer lead a normal life due to weekly pains and not feeling well.  Isn't there anything she can take to reverse the medicine's side effects as I see this as being a lifetime adventure for her.  PLEASE ADVISE on what I as a parent can do next.  I feel this is all the medicine's fault because my daughter Never had anything wrong with her until after having this shot.  I don't like reading all the articles about this shot and seeing that the company tries to blame every day life events or happenings for causing the bad things to happen to these girls.  It is definitely the GARDASIL Shot that has caused the adverse health of these young girls having problems.  12/29/2008 PCP records received for several OVs between 9/29/08 and 11/10/2008. Pt initially presented with c/o painful joints, cramping chest pain. ROS (+) for fever, chills, fatigue, 10 lb weight loss, abdominal pain, nausea, vomiting, H/A, eye pain, ear pain, sore throat, congestion, runny nose and Flu-like sx since Gardasil vax in July. Pt also reports sleep disturbance, joint pain and swelling, morning stiffness, myalgias, anxiety and depression.  Missed 5 days of school. PE (+) for joint tenderness and ache.  Assessment:  Joint disease-multiple joints.  Pain in Limb.  Loss of Weight.  AC Maxillary sinusitis.  Nausea with vomiting. F/U 10/13/08 with no improvement.  furthe heartburn, abdominal pain and bloating note with loss of appetite. Assess:  Esophagela Reflux.  Abdominal Pain-Epigastric. Bloating. F/U 11/10/08 Abdominal pain, nausea and vomiting improved on meds. Assess:  Esophageal leukoplakia.  Nausea with vomiting.  Irregular menstruation.
Felt paralyzed, could barely move arms or legs. Able to slightly wiggle toes and fingers. No strength to sit up unless assisted and could not walk or hold a glass. Went to the ER by ambulance and fire dept had to bring me out I could not walk. Left arm pain around the injection site. Swollen and warm to the touch. Headache, dizzy. Hands and feet cold and numb feeling with tingles.  Pain consistent under armpit of left arm and behind left breast constant pain. Periodic pain down at the elbow and forearm and in my abdomen.
Received 1st dose on 1/26/21 and noted arm pain and swelling with onset several hours after administration. Symptoms lasted x 1 week. Received 2nd dose on 2/26/21. Noted onset of injection site swelling within 1 hour of administration, and headache and emesis that day. Over the next 2 days reported fever, chills, body aches, diarrhea, nausea/vomiting and facial rash. Fever was up to 103F x 3 days. Also noted hives on chest. Missed work x 0.5 day. No known prior COVID infection.
Got the chills very bad, Lasted from about 4:00 PM threw (sic) the night. Couldn't get warm, Shook all night, My bones hurt and muscles. The next day, I was very tired and slept most of the day. The next day, I was very weak and couldn't do much without having to lay back down. I was unable to do much for 2 days.
"Patient" was 4yrs, her brother was 10 mos, she Received 1 dose of Varisellas on Dec. 9, 1999 and on 1-2-2000., her brother was in the hospital with a rare case of Varisellas. He was not able to take the vaccination because of his age.